Dr. Rebbeca Ann Grysiewicz, DO

Dr. Grysiewicz practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Grysiewicz's NPI, 1982852794, was assigned on September 4, 2008. Dr. Grysiewicz graduated from Midwestern University, Chicago College of Osteopathic Med in 2005. Dr. Grysiewicz holds Illinois license 036.124397.

Dr. Grysiewicz's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Grysiewicz's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Grysiewicz is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Grysiewicz to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grysiewicz practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Grysiewicz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Grysiewicz is licensed in Illinois.

CMS data shows 999 Medicare services from Dr. Grysiewicz across 7 procedure codes in 2024, for 277 Medicare patients. Medicare paid $73,106 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Grysiewicz in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grysiewicz's median patient age at 64, with 59% women.

In 2024, Dr. Grysiewicz wrote 1,682 Medicare Part D claims for 174 patients. 89% of them were for generic drugs. CMS names the drug for 1,428 of them, across 40 drugs with 11 or more claims each, at $1,174,129 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Grysiewicz for performance year 2024, reported as part of a group. Dr. Grysiewicz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grysiewicz as offering telehealth.

Dmand AI links 2 papers to Dr. Grysiewicz in 2014. 2014 was the busiest year, with 2. The most frequent topics are Stroke. Dr. Grysiewicz has published most often in J Stroke Cerebrovasc Dis. Dr. Grysiewicz's most frequent co-authors are Venkatesh Aiyagari, MD and Basim M. Uthman, MD.

CMS Open Payments shows 7 general payments to Dr. Grysiewicz from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $74.

Dr. Grysiewicz graduated from Midwestern University, Chicago College of Osteopathic Med in 2005.